Who owns the S SKINVIVE BY JUVÉDERM trademark?

The S SKINVIVE BY JUVÉDERM trademark is owned by Allergan Holdings France SAS.

What class is the S SKINVIVE BY JUVÉDERM trademark registered in?

The S SKINVIVE BY JUVÉDERM trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for S SKINVIVE BY JUVÉDERM?

The USPTO serial number for S SKINVIVE BY JUVÉDERM is 97006113.

What is the registration number for S SKINVIVE BY JUVÉDERM?

S SKINVIVE BY JUVÉDERM is registered under USPTO registration number 7108819.

SSK

USPTO Trademark Record

REGISTERED

S SKINVIVE BY JUVÉDERM

SN 97006113·Reg 7108819·Filed Sep 01, 2021

Owner Allergan Holdings France SAS

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

S SKINVIVE BY JUVÉDERM (Serial No. 97006113), Registration No. 7108819, is a registered US trademark filed on Sep 01, 2021 by Allergan Holdings France SAS. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: July 11, 2029

Mark Intelligence

S SKINVIVE BY JUVÉDERM (Reg. #7108819) is a registered US trademark that has been protecting its owner, Allergan Holdings France SAS, since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 01, 2021

SERIAL

97006113

REG#

7108819

REGISTERED

Jul 11, 2023

Owner

Applicant

Allergan Holdings France SAS

Entity

Not Provided

Address

Tour CBX, 1 passerelle des Reflets, Courbevoie, 92400

Country

Attorney

NameMatthew O. Brady

Docket

ABVT116381

Address

18655 Teller Avenue, Mail Stop: AND-250C, Irvine, CA 92612, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 01, 2021

Serial Number97006113

Registration No.7108819

Registration DateJul 11, 2023

Status DateJul 11, 2023

Published for OppositionApr 05, 2022

Mark TypeDesign with words

Attorney DocketABVT116381

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: May 15, 2023

First use in commerce: May 15, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

43 events

AMENDMENT UNDER SECTION 7 - PROCESSED

Nov 25, 2025

AMENDMENT UNDER SECTION 7 - PROCESSED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 17, 2025

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 7 REQUEST RECEIVED

Sep 03, 2025

TEAS SECTION 7 REQUEST RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jul 11, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 11, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jun 08, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

NON-FINAL ACTION E-MAILED

Jun 07, 2023

NON-FINAL ACTION E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jun 07, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 07, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

SU-EXAMINER'S AMENDMENT WRITTEN

Jun 07, 2023

SU-EXAMINER'S AMENDMENT WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jun 07, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jun 07, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jun 07, 2023

EXAMINER'S AMENDMENT ENTERED

SU - NON-FINAL ACTION - WRITTEN

Jun 07, 2023

SU - NON-FINAL ACTION - WRITTEN

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 01, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

May 31, 2023

SOU EXTENSION 2 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

May 31, 2023

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 30, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

May 23, 2023

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

May 23, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

May 23, 2023

SOU EXTENSION 2 FILED

USE AMENDMENT FILED

May 23, 2023

USE AMENDMENT FILED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 10, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 10, 2023

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Apr 10, 2023

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 10, 2023

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 02, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Nov 30, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Nov 30, 2022

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Nov 30, 2022

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 31, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 05, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 05, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 16, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO EXAMINER

Mar 01, 2022

ASSIGNED TO EXAMINER

EXAMINERS AMENDMENT -WRITTEN

Mar 01, 2022

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 01, 2022

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 01, 2022

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 01, 2022

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 01, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Oct 15, 2021

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 14, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 04, 2021

NEW APPLICATION ENTERED

S SKINVIVE BY JUVÉDERM

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Allergan Holdings France SAS

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Matthew O. Brady

Resources

Company